1/30
Looks like no tags are added yet.
Thombosis
Formation of blood clots; obstructs blood flow and prevents excessive blood loss from trauma
Plasminogen
Dissolves the clots and prevents clots from forming; inactive protein bound to fibrin thats to become a component of the blood clot
Plasmin/Fibrinolysin
Breaks down and dissolves the clot
Thrombogenesis
Formation of clots
Thrombolysis
Dissolving of clots
Incomplete Arterial Blockage
Deficient blood flow; ischemia, skin may be slightly cool with a weak pulse
Complete Arterial Blockage
Blood obstruction; necrosis — pulse is absent, skin may turn black
Venous Stasis
Blood flow is slowed down; edema — DVT
Anticoagulants
Used in thrombotic disorders — most effective in preventing venous thrombus
Does not dissolve clots, but prevents the formation of clots
Antiplatelets
Used to prevent arterial thrombosis
Thrombolytics
Dissolve thrombi and limit tissue damage in thromboembolic disorders
Heparin
Anticoagulant; inhibits clot formation, used for PE or DVT prevention = given IV or SUBQ only
Given for:
Hx of PE, MI, HF, or major surgery, bed rest more than 5 days, atrial fibrillation
Adverse: bleeding, Heparin-induced thrombocytopenia (HIT)
Contraindications: GI bleed, intracranial hemorrhage, HTN (intense blood flow), alcoholism (liver damage), HIT
BLACK BOX WARNING: SLOW IV INFUSION
Heparin Nursing Considerations
Monitor for HIT
Platelet and aPTT/PTT = measuring how long blood takes to clot (high = long time to clot)
Reversal agent = Protamine Sulfate = neutralizes drug
Enoxaparin (Lovenox)
Anticoagulant, LMWH; similar use as heparin — given SUBQ for thrombotic disorders.
Less monitoring, but still at risk for HIT
Given to patients who are under bed rest to prevent blood stasis and clotting
Warfarin (Coumadin)
Vitamin K Antagonist; helps the patient not form clots
Long term use used for the prevention or management of: DVT, PE, Afib, and prosthetic heart values (body wants to fight the foreign materials)
Adverse: Bleeding/hemorrhage
Contraindications: GI bleed, intracranial hemorrhage, HTN, alcoholism
BLACK BOX WARNING: fetal bleeding, do not give to someone who is pregnant
Vitamin K Antagonist Nursing Considerations
Lots of drug interactions
Frequent monitoring: INR/PT = measure how long blood takes to clot; also monitoring for therapeutic serum range
Diet changes — foods high in vitamin K (leafy veggies) reverse warfarin = do not change intake amount
Emergent reversal agent: Prothrombin Complex Concentrate (PCC — called K-Centra) or Fresh Frozen Plasma (FFP)
Must be greater than the risk for a clot to give this medication
Anticoagulant Teaching
Bleeding symptoms: bruising, bleeding gums, prolonged bleeding episodes, dizziness, lightheadedness, hypotension — low Hbg and Hct
Blood dark urine, hemoptysis, SOB
Gi issues are side effects: dyspepsia, nausea, upper abdominal pain, GI hemorrhage, and diarrhea
Discourage NSAIDs — increase risk for excessive bleeding and may damage stomach lining
Clopidogrel
ADP Receptor Antagonists; inhibits stickiness of platelets to prevent clot formation
Used for: Afib, prevention of MI and strokes, AFTER MI treatment (stent/PCI) to prevent attack on foreign material
Adverse: rash, purpura, bleeding/hemorrhage
Contraindications: Active bleeding
ADP Receptor Antagonists Nursing Considerations
Patient cannot stop taking this medication unless instructed by provider — could cause immense clotting if stopped
Watch for bleeding and report to provider
Avoid NSAIDs
Aspirin
Thromboxane A2 Inhibitor; helps prevent platelets from crowing (aggregation) — dose dependent (81mg is the baby aspirin given for anti-platelet effects)
Used for MI/stroke prevention and stent/PCI
Adverse: bleeding/hemorrhage
Thromboxane A2 Inhibitor Nursing Considersations
Teach the difference between baby aspirin and regular OTC doses
Eptifibatride
Glycoprotein IIB/IIIA Receptor Antagonist; used for MI treatment and stent/PCI with aspirin
Adverse: bleeding/hemorrhage
Contraindications: GI bleed, intracranial hemorrhage, HTN
Cilostazol
Phosphodiesterase-3 Enzyme Inhibitor; used for intermittent claudication from peripheral arterial disease (PAD claudication = pain with activity that is caused by reduced blood flow to limbs)
BLACK BOX WARNING: DO NOT GIVE TO PATIENTS WITH HF
Anagrelide
Used for patients with excessive amounts of platelets (thrombocythemia)
Alteplase, Tenecteplase
Thrombolytics; dissolves clots to reestablish blood flow to prevent tissue damage
Adverse: bleeding (patient must meet certain criteria for this drug), angioedema, highest risk for brain hemorrhage if given for ischemic stroke
Contraindications: bleeding/blood thinners, severe HTN and/or hypotension, major surgery, aneurysm (blood vessels is very weak, risk for bleeding is too great)
Thrombolytic Nursing Considerations
Neuro checks every 15 minutes, any change could indicate brain hemorrhage
Administration requires special training and patient must be certain criteria
Avoid IV sticks/NG tubes
Monitor labs and for bleeding
Encourage use of soft bristle toothbrush (to reduce risk of bleeding gums)
Hematopoiesis
Blood cell production
Epoetin Alfa
Stimulates RBC production; treats anemia associated with chemotherapy
Adverse: Hypertension
BLACK BOX WARNING: End-stage renal disease/dialysis patients; if HBG = 12 or above (11 w/CKD) can cause stroke
Epoetin Alfa Nursing Considerations
Monitor RBG, Hgb, and Hct
Give at end of dialysis
Filgrastim
Stimulates WBCs to help fight infection; used with patients with neutropenia — given SUBQ or IV
Adverse: flu-like symptoms, bone pain
Contraindications: allergy
Filgrastim Nursing Considerations
Help patient understand how to prevent infection; good hygiene, avoiding certain foods